Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 1, 2015
Pharmacy Choice - Pharmacy News - September 1, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
9/1/15 - Global Cardiac Resynchronization Therapy (CRT) Devices Market 2015-2019 with Boston Scientific, Medtronic & St Jude Medical Dominating
--Research and Markets has announced the addition of the "Global Cardiac Resynchronization Therapy Devices Market 2015-2019" report to their offering. For instance, Medtronic received FDA approval for its Viva CRT-D, which significantly improves the response rate for the treatment and provides economic benefits by reducing the number of hospitaliza
9/1/15 - US FDA Approves Initiation of ViroMed's VM202 for Phase III Clinical Study of Chronic Non-Healing Ischemic Diabetic Foot Ulcer
ViroMed Co., Ltd. today announced that the company has received an approval from the US FDA to launch a pivotal Phase III clinical trial utilizing VM202, a proprietary DNA based biopharmaceutical, for chronic non-healing ischemic diabetic foot ulcers. This is the first gene therapy trial specifically targeting ulcers which affects millions of peopl
8/31/15 - Ascletis Initiates Phase II Clinical Trial of Its Interferon-Free HCV Regimen in Taiwan
SHAOXING, China, Aug. 31, 2015/ PRNewswire/-- Ascletis today announced it received the approval from the Taiwan Food and Drug Administration to start phase II clinical trial for its all-oral interferon- free regimen to treat chronic hepatitis C. The regimen contains Ascletis' two direct-acting antiviral agents, the NS3/4A protease inhibitor ASC08 a
8/31/15 - Boston Scientific Announces FDA Approval of Innova Vascular Self-Expanding Stent System
By a News Reporter-Staff News Editor at Pharma Business Week-- Boston Scientific Corporation has received Food and Drug Administration approval for the Innovaâ?¢ Vascular Self-Expanding Stent System, an advanced treatment option for patients with narrowing or blockages in the superficial femoral artery or proximal popliteal artery.
8/31/15 - Lannett Receives FDA Approval, Launches Generic Antidepressant Drug ABILIFY®
By a News Reporter-Staff News Editor at Pharma Business Week-- Lannett Company, Inc. announced that its Silarx Pharmaceuticals, Inc. subsidiary has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Aripiprazole Oral Solution 1 mg/mL, the generic version of the antidepressant drug ABILIFY.
8/31/15 - Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study
Mitralign, Inc., an innovative provider of percutaneous valve repair solutions, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption approval for the Company to conduct an early feasibility study to examine its Percutaneous Tricuspid Valve Annuloplasty System. â??Percutaneous repair of the tricuspi

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement